IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+26.96%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$271M
AUM Growth
+$271M
(+68%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
8.8%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
66
New
21
Increased
14
Reduced
12
Closed
4
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$9.05M |
| 2 |
Alkermes
ALKS
|
$8.5M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.47M |
| 4 |
Wave Life Sciences
WVE
|
$5.63M |
| 5 |
Travere Therapeutics
TVTX
|
$4.7M |
Top Sells
| 1 |
Incyte
INCY
|
$13.2M |
| 2 |
Exelixis
EXEL
|
$8.23M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.17M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.16M |
| 5 |
SHPG
Shire pic
SHPG
|
$3.42M |
Sector Composition
| 1 | Healthcare | 95.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $22.2M | 8.21% | 235,522 +10,000 | +4% | +$943K |
|
2
Gilead Sciences
GILD
$140B
| $18.1M | 6.68% | 278,284 +65,000 | +30% | +$4.23M |
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $13M | 4.8% | 31,630 +300 | +1% | +$123K |
|
|
STML
4
DELISTED
Stemline Therapeutics, Inc.
STML
| $10.2M | 3.78% | 796,245 +210,315 | +36% | +$2.7M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.95M | 3.68% | 73,641 | – | – |
|
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $9.4M | 3.47% | 51,122 -39,000 | -43% | -$7.17M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $9.13M | 3.37% | 103,600 -22,200 | -18% | -$1.96M |
|
|
8
PTC Therapeutics
PTCT
$3.92B
| $9.05M | 3.34% | +240,493 | New | +$9.05M |
|
|
9
Incyte
INCY
$16.5B
| $8.73M | 3.22% | 101,500 -153,000 | -60% | -$13.2M |
|
|
10
Alkermes
ALKS
$4.78B
| $8.5M | 3.14% | +233,000 | New | +$8.5M |
|
11
Illumina
ILMN
$15.8B
| $7.8M | 2.88% | 25,100 -8,500 | -25% | -$2.64M |
|
12
Halozyme
HALO
$8.56B
| $7.66M | 2.83% | 475,633 +77,000 | +19% | +$1.24M |
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $7.22M | 2.67% | 269,000 -13,065 | -5% | -$351K |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.18M | 2.65% | 151,117 +136,117 | +907% | +$6.47M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| $6.06M | 2.24% | 213,061 -106,383 | -33% | -$3.03M |
|
16
Enanta Pharmaceuticals
ENTA
$180M
| $5.83M | 2.15% | 61,000 +18,000 | +42% | +$1.72M |
|
|
17
Exelixis
EXEL
$10.1B
| $5.79M | 2.14% | 243,534 -346,000 | -59% | -$8.23M |
|
18
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.7M | 2.11% | 64,284 -28,000 | -30% | -$2.48M |
|
|
19
Wave Life Sciences
WVE
$1.53B
| $5.63M | 2.08% | +145,000 | New | +$5.63M |
|
|
SAGE
20
DELISTED
Sage Therapeutics
SAGE
| $5.41M | 2% | 33,996 +18,000 | +113% | +$2.86M |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $5.11M | 1.89% | 93,000 | – | – |
|
|
22
Travere Therapeutics
TVTX
$1.56B
| $4.7M | 1.74% | +208,000 | New | +$4.7M |
|
23
Amgen
AMGN
$155B
| $4.56M | 1.68% | 24,000 | – | – |
|
|
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.46M | 1.65% | 60,900 +18,400 | +43% | +$1.35M |
|
25
Ionis Pharmaceuticals
IONS
$6.79B
| $3.88M | 1.43% | 47,781 +7,781 | +19% | +$631K |
|